According to FutureWise analysis the market for protein therapeutics in 2023 is US$ 350.6 billion, and is expected to reach US$ 616.96 billion by 2031 at a CAGR of 7.3%.
Protein-based therapies made synthetically are referred to as protein therapeutics. They are strong, quick-acting medications that give the body a precise dosage of tiny protein molecules. They often include recombinant versions of naturally occurring proteins such as human growth hormones (HGH), follicle-stimulating hormones, insulin, fusion proteins, erythropoietin, monoclonal antibodies, and insulin. They support the treatment of long-term medical conditions such as cancer, diabetes, neurodegenerative diseases, and autoimmune, hematological, hormonal, and genetic problems. Protein therapies delivered orally, intravenously, or through combination therapy are also used.
According to their clinical applications, therapeutic proteins are one of the best selections for biologicals. Therapeutic protein use has recently been rising steadily. Protein therapies are widely utilized to treat several illnesses, including cancer, AIDS, etc. The interest in therapeutic proteins is increasing due to recent developments in pharmaceutical biotechnology. Clinical studies are being conducted in this area to treat various ailments, and pharmaceutical companies are showing interest in therapeutic proteins. The therapeutic protein will most likely be clinically successful among the many therapy choices. Recent clinical trials show that therapeutic proteins may offer a safe and viable approach to treat various diseases. Still, there are some disadvantages, such as immunogenic issues, safety, and protein stability issues. One of the major variables propelling the market for protein therapies is the rising incidence of chronic illnesses.
Due to the advancement of plasma-derived medicines and the rise in chronic illness, the market for protein therapeutics is growing. The prevalence of many diseases, including cancer, metabolic disorders, genetic disorders, and immunological diseases, is expected to propel, further increasing the demand for protein-based treatments. The market for protein therapeutics is expected to expand significantly as a result. The industry is expanding as a result of increased proteomics research, too. Moreover, pharmaceuticals made from therapeutic proteins are a sizable class of drugs that help those who need novel treatments the most. A wide variety of therapeutic indications, including cancer, autoimmunity/inflammation, exposure to infectious agents, and hereditary illnesses, have recently been treated with recently approved recombinant protein therapies. Additionally, recent advancements in protein engineering technology have enabled drug developers and manufacturers to modify and capitalize on advantageous functional traits of target proteins while retaining their products' safety, efficacy, or both. The market for protein therapies is also being boosted by the rising demand for protein therapeutics and the swift rise in the use of plasma medicines to treat chronic disorders. However, several factors, including the high cost of protein therapies and the strict legal criteria for product approval, severely restrict the market for protein therapeutics. The high cost of installation and maintaining lab equipment and the stringent government rules controlling protein treatments also restrict the market growth for protein therapeutics.
FutureWise Market Research has published a report that provides an insightful analysis of protein therapeutics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the protein therapeutics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.